today announced its Phase 2 study failed to show treatment benefit in patients with chronic active pulmonary sarcoidosis. The Phase 2 RESOLVE-Lung study (NCT05314517) evaluated the efficacy and ...

A spirometry test is one way to distinguish the type of lung disease. Emphysema and chronic bronchitis are ... you’re sitting and haven’t been active. This symptom isn’t as common in people ...

For individuals with chronic lung conditions, the winter season and ... “So, that sort of damage and scarring between the active bits of the lungs means that people find it harder to breathe ...

For individuals with chronic lung conditions, the drop in temperatures ... “So, that sort of damage and scarring between the active bits of the lungs means that people find it harder to breathe ...

today announced its Phase 2 study failed to show treatment benefit in patients with chronic active pulmonary sarcoidosis. The Phase 2 RESOLVE-Lung study (NCT05314517) evaluated the efficacy and ...

The Phase 2 RESOLVE-Lung study (NCT05314517) evaluated the efficacy and safety of namilumab, an investigational anti-GM-CSF monoclonal antibody administered once-monthly as a subcutaneous injection, ...